Article
15 Oct 2026
FDA Peptide Compounding Policy: What A Temporary Enforcement Reprieve Could Mean For Pharmacies
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
25 Aug 2026
FDA Advisory Committee Voted Yes On Six Peptides. Now What? The Regulatory Road Ahead
Article
17 Aug 2026
FDA Extends DSCSA Exemption For Small Pharmacies Through November 27, 2027: What Pharmacies Need To Know
Article
05 Aug 2026
FDA PCAC Recommends Six Peptides For The 503A Bulks List: What Compounding Pharmacies Need To Know
Article
13 Jul 2026
CMS Releases 2027 OPPS Proposed Rule: Key Changes For Hospitals, Health Systems And Healthcare Providers
Article
30 Jun 2026
Cassidy’s 340B Reform Discussion Draft Signals A Shift In The Future Of The 340B Program
Article
26 Jun 2025
Color Us Intrigued: Staying Ahead Of FDA's Regulatory Changes For Colors
Article
29 May 2025
State Importation Revamped: FDA Announces Enhancements To State Importation For Eligible Prescription Drugs
Article
28 May 2025
Patent Predicament: FTC Revives Challenges To Over 200 Patent Listings
Article
03 Feb 2025
Understanding The FDA's Ban On FD&C Red No. 3: Implications And Protective Measures For Companies
Article
20 Jan 2025
4 Potential FDA Drug Approvals To Watch In 2025
Article
17 Oct 2024
Safeguarding Clinical Trial Data In The Age Of Artificial Intelligence & Data Breaches
Article
03 Oct 2024
Implications Of FDA's Stem Cell Win In The 9th Circuit
Article
10 Jul 2024
U.S. Supreme Court Overrules Chevron: Sparks Potential Major Shift In Food And Drug, Trade, And Consumer Protection Laws
Article
21 Nov 2023
Fanning The Flames: FTC Takes Action Against Alleged Improper Orange Book Patent Listings
Article
29 Aug 2023
Looking For A Switch? 5 Considerations For Optimizing Rx-To-OTC Drug Product Switches
Article
04 May 2023
Portfolio Strategy: How To Drive Deal Value With Drug Target Analysis
Article
11 Apr 2023
FDA Shakeups: 5 Developments Life Sciences Companies Should Monitor In 2023
Article
05 Oct 2022
5 Ways Sponsors Can Prepare For Increased Clinical Trial Fraud Scrutiny
Article
14 Apr 2021
Vaccine Readiness, Preparing Your Company For Vaccines And Avoiding Employee Claims - Webinar Recording